Brimonidine Tartrate
Showing 26 - 50 of 271
Preferences & Treatment Satisfaction Drivers in Rosacea Patients
Completed
- Rosacea
- Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251)
- +6 more
-
Boston, Massachusetts(unnamed)
Mar 30, 2020
Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,
Completed
- Presbyopia
- +2 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Glendale, California
- +4 more
Oct 18, 2022
Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,
Recruiting
- Presbyopia
- +4 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Glendale, California
- +3 more
Aug 3, 2022
Dermatochalasis of Eyelid, Ptosis, Eyelid, Ectropion Trial in Louisville (Brimonidine Topical)
Recruiting
- Dermatochalasis of Eyelid
- +3 more
- Brimonidine Topical
-
Louisville, KentuckyUniversity of Louisville
Jul 27, 2022
Presbyopia, Near Vision, Miosis Trial in China (Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic
Not yet recruiting
- Presbyopia
- +3 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Wenzhou, Zhejiang, China
- +18 more
Sep 19, 2023
Presbyopia, Refractive Error, Near Vision Trial in Glendale (Aceclidine + Brimonidine, Aceclidine, Brimonidine)
Recruiting
- Presbyopia
- +4 more
- Aceclidine + Brimonidine
- +2 more
-
Glendale, CaliforniaSite #101
Jan 10, 2023
Presbyopia, Near Vision, Miosis Trial in Chandler, Glendale (Aceclidine+Brimonidine combination ophthalmic solution, Placebo,
Recruiting
- Presbyopia
- +3 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Chandler, Arizona
- +1 more
Mar 2, 2023
Presbyopia, Near Vision, Miosis Trial in Newport Beach (Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine,
Not yet recruiting
- Presbyopia
- +3 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Newport Beach, CaliforniaSite #201
Feb 6, 2023
Glaucoma, Open-Angle, Ocular Hypertension Trial in Winston-Salem (Brinzolamide/brimonidine ophthalmic suspension, Simbrinza
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- Brinzolamide/brimonidine ophthalmic suspension
- Simbrinza 0.2%/1% Ophthalmic Suspension
-
Winston-Salem, North CarolinaJames D. Branch Ophthalmology
Aug 18, 2022
Posterior Capsule Opacification, Ocular Hypertension Trial in Patra (Brinzolamide/Brimonidine FC, Brimonidine 0.2%, Artificial
Completed
- Posterior Capsule Opacification
- Ocular Hypertension
- Brinzolamide/Brimonidine FC
- +2 more
-
Patra, Achaia, GreeceUniversity Hospital of Patras
Jun 23, 2019
Presbyopia Trial in Mexico City (Pilocarpine, brimonidine, oxymetazoline, hyaluronic acid, bromfenac (PBOHB) compound)
Recruiting
- Presbyopia
- Pilocarpine, brimonidine, oxymetazoline, hyaluronic acid, bromfenac (PBOHB) compound
-
Mexico City, MexicoOptall Vision
Aug 14, 2021
Patient With Facial Erythema Trial in Assiut (Tranexamic Acid 500 MG)
Completed
- Patient With Facial Erythema
- Tranexamic Acid 500 MG
-
Assiut, EgyptAzhar University
Jun 9, 2023
Hand-foot Syndrome Trial in Düsseldorf (Brimonidine Tartrate)
Terminated
- Hand-foot Syndrome
- Brimonidine Tartrate
-
Düsseldorf, GermanyUniversitätsklinikum Düsseldorf, Klinik für Dermatologie
Jan 7, 2019
Open-angle Glaucoma, Ocular Hypertension Trial in Fort Worth (Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension,
Terminated
- Open-angle Glaucoma
- Ocular Hypertension
- Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension
- +2 more
-
Fort Worth, TexasContact Alcon for Locations (Europe, Asia, and Latin America)
May 16, 2019
Glaucoma Trial in Indianapolis (fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution, fixed
Completed
- Glaucoma
- fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution
- fixed combination of dorzolamide hydrochloride timolol maleate ophthalmic solution
-
Indianapolis, Indiana(unnamed)
Apr 10, 2019
Glaucoma, Open-Angle Trial (Brimonidine Tartrate, Dorzolamide (as Dorzolamide Hydrochloride) 20 Mg/mL and Timolol (as Timolol
Completed
- Glaucoma, Open-Angle
- Brimonidine Tartrate
- +5 more
- (no location specified)
May 24, 2019
Presbyopia Trial in Mexico City (PBO to control presbyopia symptoms)
Completed
- Presbyopia
- PBO to control presbyopia symptoms
-
Mexico City, MexicoOptall Vision
Aug 14, 2021
Glaucoma Trial (Brimonidine/timolol fixed combination drops added to travoprost, Brinzolamide/timolol fixed combination drops
Completed
- Glaucoma
- Brimonidine/timolol fixed combination drops added to travoprost
- Brinzolamide/timolol fixed combination drops added to travoprost
- (no location specified)
Dec 16, 2020
Primary Open-angle Glaucoma Trial in Bogotá, Zapopan (PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic)
Recruiting
- Primary Open-angle Glaucoma
- PRO-122
- +6 more
-
Bogotá, Bogotá D.C., Colombia
- +1 more
Dec 22, 2021
Rosacea Trial in Canada, United States (Brimonidine 0.33% gel (Br), CD07805/47 (Br) gel, Ivermectin 1% cream (IVM))
Completed
- Rosacea
- Brimonidine 0.33% gel (Br)
- +3 more
-
Fort Smith, Arkansas
- +12 more
Feb 16, 2021
Glaucoma, Ocular Hypertension Trial in Dallas (fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic
Completed
- Glaucoma
- Ocular Hypertension
- fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution; bimatoprost 0.03% ophthalmic solution
- bimatoprost 0.03% ophthalmic solution; hypromellose 0.2% eyedrops
-
Dallas, Texas(unnamed)
Apr 10, 2019
Open Angle Glaucoma, Ocular Hypertension Trial in Porto Alegre (PSLT, Prostaglandin analogue eye drops)
Recruiting
- Open Angle Glaucoma
- Ocular Hypertension
- PSLT
- Prostaglandin analogue eye drops
-
Porto Alegre, RS, BrazilUniversidade Federal do Rio Grande do Sul
Feb 11, 2022
Rosacea Trial (Brimonidine Topical Gel, 0.33 percent (Perrigo), Brimonidine Topical Gel, 0.33 percent (Reference), Placebo gel)
Completed
- Rosacea
- Brimonidine Topical Gel, 0.33 percent (Perrigo)
- +2 more
- (no location specified)
Oct 20, 2021
Glaucoma, Ocular Hypertension Trial in Newark, Montreal (Fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5%,
Completed
- Glaucoma
- Ocular Hypertension
- Fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5%
- +2 more
-
Newark, New Jersey
- +1 more
Apr 10, 2019